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Dermatitis herpetiformis is a chronic subepidermal 
vesicular autoil'lul'Iune skin disease characterized by a 
strong association with the human leukocyte antigen 
A1-B8-DR3-DQ2 haplotype. Although the strongest 
major histocompatibility complex association has 
been shown to be with the DQw2 (DQB1 *02011 
DQA1 *0501) heterodimer, recent evidence has sug-
gested that there may be up to three susceptibility 
loci within the major histocompatibility complex. 
Tumor necrosis factor-alpha (TNF-a) is a cytokine 
with a broad range of proin6ammatory, immuno-
modulating, and catabolic activities. We have re-
cently described the first known polymorphism in the 
human TNF-a gene, which is biallelic and lies in the 
promoter region. The rare allele, TNF2, is in strong 
D ermatitis herpetiformis (DH) is a chronic vesicular skin disease characterized histologically by subepi-dermal blister formation and an intense infiltrate of neutrophils in the adjacent dermal papillae. Direct immunofluorescence of uninvolved skin shows 
granular deposits of IgA and usually C3 in the demlal papillae and 
superficial dermis [1]. One of the most striking features of tlus 
disease is the very strong association with the major lustocompat-
ibility complex (MHC) haplotype human leukocyte antigen (HLA) 
Al-B8-DRJ-DQ2 [2,3] . Witllin tlus haplotype, the strongest asso-
ciation is believed to be with the HLA-DQ2 heterodimer [4]. DH 
and celiac disease share several features, including villous atrophy, 
which is correctable by withdrawal of dietary gliadin, and their 
strong association with the HLA Al-B8-DR3-DQ2 haplotype 
[2,5]. It has been demonstrated recently that gluten-reactive T cells 
can be isolated from patients with celiac disease, and the majority of 
these cells are restricted by the DQBl *0201/DQAl *0501-encoded 
heterodimer [6] , possibly explaining the MHC association. There is 
some evidence, however, that the MHC disease susceptibility gene 
for DH lies closer to the complement cluster, wluch is in the class 
III region of the MHC, than to the class II region containing the 
HLA-DR and -DQ genes [2]. 
Tumor necrosis factor-alpha (TNF-a) is an inducible cytokine 
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linkage disequilibrium with the human leukocyte 
antigen A1-B8-DR3-DQ2 haplotype. We therefore 
examined TNF-a genotypes in patients with derma-
titis herpetiformis and controls and compared the 
association with that of the class II alleles. Although 
TNF2 is strongly associated with dermatitis herpeti-
formis, this was weaker than the association with the 
class II loci, with DQw2 (DQB1 *02011DQA1 *0501) 
showing the strongest disease association. Of the four 
patients negative for this marker, only one carried 
the TNF2 allele. These results indicate that TNF2 is 
not a major disease susceptibility marker, although 
our results do not exclude a minor role. Key words: 
major /,istocompatibility complexlpolymorpltismlim"umoge_ 
netics. ] Invest Dermatol 104:856-858, 1995 
with a broad range of proinflammatory, catabolic, and immuno-
stimulatory actions. These include induction of interleukin (IL)-l, 
IL-6, IL-8, and TNF-a itself; stimulation of prostaglandin E2 , nitric 
oxide synthase, and collagenase production; neutrophil activation; 
increased HLA class I and II expression; and increased Band T cell 
proliferation and immunoglobulin synthesis . The major source of 
TNF is the activated macrophage, but expression also occurs in 
keratinocytes, natural killer cells, Band T lymphocytes, and 
mesangial kidney cells [7]. The gene encoding TNF-a lies witllin 
the class III region of the MHC, approximately 350 kilobase pairs 
(kb) telomeric of the complement cluster and 300 kb centromeric 
of the HLA-B locus [8]. 
Regulation of production of TNF-a is transcriptional and post-
transcriptional [9]. After stimulation of macrophages with lipopoly-
saccharide, TNF-a transcription rises threefold, mRNA levels rise 
50-100-fold, and protein secretion rises by about 10,OOO-fold over 
basal levels [7). Thus, gene expression is regulated at multiple 
levels. The 5' region (a 1.2-kb stretch of DNA between the TNF 
genes) contains sequences that control transcription of TNF-a, 
whereas regions in the untranslated region of exon 4, a stretch of 
approximately 800 bases, control mRNA stability and translational 
efficiency [10]. In humans, production ofTNF-a has been shown to 
correlate with HLA-DR alleles: DRJ- and DR4-positive individ-
uals produce high levels [11,12]; DR2-positive individuals produce 
low levels [13]. 
We have recently described the first known polymorplusm 
within the human TNF-a gene. Tlus lies in the prompter region, in 
a consensus sequence for binding of the transcription factor AP-2, 
and involves the substitution of guanine by adenosi.ne in the 
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Table I. Comparative Analysis of MHC Alleles in DH 
Patients and Controls 
Alleles 
Present Controls DH Odds Ratio 
TNF2" 45%b (n = 55)' 81% (n = 52) 5.2 (2.1-11.7)" 
DRB1'0301' 39% (n = 61) 87% (n = 52) 10.5 (4.1-27.1) 
DQB1'02011 
DQA1 *0501 30% (n = 61) 91% (n = 46) 23 .6 (7 .4-75.2) 
" TNF-o genotyping was by single-stranded conformation polymorphism analysis. 
/, Carriage rates arc expressed as a percentage. 
, The number of individuals typed at each locus is given in parentheses. 
(/95% confidence Limits of the odds ratio arc given in parentheses. 
, MHC class II typing was performed with allele-specific oligonucleotides. 
uncommon (TNF2) allele [14]. We have also shown the TNF2 
allele to be very strongly associated with the HLA Al -BS-DR3-
DQ2 haplotype in a northern European population [15]. We 
therefore genotyped TNF in a group of patients with DH and in 
controls to see whether tlus polymorplusm plays a role in the MHC 
association with tlus disease. 
MATERlALS AND METHODS 
Patient Selection The study group consisted of 55 patients with DH and 
61 unrelated healthy controls. All study subjects were Caucasians living in 
the North of England. Patients with the classic clinica] presentation of 
DH-intensely pruritic groups of excoriated vesicles concentrated over the 
knees, elbows, and buttocks-were selected from the dennatology clinic. Tn 
all patients, the diagnosis was confirmed histologically by subepidermal 
blister formation with a neutrophilic infiltrate in the adjacent dermal 
papillae. Direct immunofluorescence of uninvolved sk.in showed granular 
deposits of IgA and C3 in the dermal papillae and superficial dermis. All of 
the patients had been treated initially with a gluten-free diet and dapsone. 
MHC Genotyping Polymerase chain reaction amplifications of the 
DRB, DQA, and DQB loci were performed using primers designed and 
provided in ;. British Society for H.istocompatibility and Immunogenetics 
k.it. The amplified products were detected using sequence-specific oligonu-
cleotides from tlus k.it accord.ing to tile metl10d of Vaughan el al [16,17)' 
The oligonucleotide probes were labeled witll digoxigenin ddUTP (Boehr-
inger Mmmheim Biochemica), detected using alkaline-phosphatase-conju-
gated antibody to digoxigenin, developed by the chemiluminescent 
substrate 4-methm.:y-4-(3-phosphatphenyl)spiro(1, 2-d.ioxetan-3 , 2' -ada-
mantan) (Lunugen PPD; Boehringer Mannheim Biochemica), mId visual-
ized on X-ray film. . 
A 107-base-pair stretch of the TNF-a promoter was amplified by 
polymerase chain reaction (cycling: 94°C for 3 min, 60°C for 1 min, and 
noc for 1 min; followed by 35 cycles of 94°C for 1 min, 60°C for 1 min, 
and 72°C for 1 min; with a final cycle of 94°C for 1 min, 60°C for 1 min, 
and 72°C for 5 min) . The biallelic polymorpllism at position - 308 of tile 
TN F-a promoter was screened using single-stranded conformation poly-
morplusm analysis, as described previously (15). Fifty microliters of poly-
merase chain reaction product was denatured witll 2.5 /1-1 1 M NaOH and 
heated to 42°C for 5 min before adding 6 /1-1 of 100% formamide. The 
samples were loaded on a 9% polyacrylamide gel and subjected to electro-
phoresis for 16 h at 4 V Icm and 4°C. The DNA was stained with etludium 
bromide and visualized under ultraviolet light. 
Primers were as follows: for DRB, 5'-CCCCACAGCACGTTTCTTG-3 ' 
and 5'-CCGCTGCACTGTGAAGCTCT-3'; for DQA, 5'-ATGGTGTA-
AACTTGTACCAGT -3' and 5'-TTGGTAGCAGCGGTAGAGTTG-3'; for 
DQB, 5'-CATGTGCTACTTCACCAACGG-3' and 5'-CTGGTAGTTGT-
GTCTGCACAC-3'; mId for TNF-a, 5'-AGGCAATAGGTTTTGAGGGC-
CAT -3' and 5'-TCCTCCCTGCTCCGA TTCCG-3'. 
Statistical Analysis Analysis was performed on allele ca.rriage. A 2 X 2 
table was constructed for each allele, and Fisher exact test was used to 
deternune statistical sign.ificance. Odds ratios were calculated using the 
Woolf-Haldane method, along with the 95'Y. confidence limits. 
RESULTS 
We studied 61 normal individuals and 52 patients. All were typed 
at the TNF, DR, and DQ loci except for six controls for TNF 
typing and six patients for DQ typing. There was an association of 
each of the alleles with DH (Table I). Tlus was weakest with TNF2 
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and increased with the class II markers, being lughest with car. iage 
of the DQBl *0201/DQAl *0501 alleles. 
Because of the small numbers of ind.ividuals negative for any of 
the alleles, we were not able to exanune the independent disease 
association of any allele separate from the others. However, of the 
four patients who d.id not carry the DQBl *0201/DQAl *0501 
alleles, three were TNFl homozygotes and only one was heterozy-
gous at the TNF locus. 
DISCUSSION 
The association ofDH with the HLA Al-BS-DR3-DQ2 haplotype 
has been clearly demonstrated both in this 3l1d in previous stud.ies 
[3,4]. The primary d.isease association locus is thought to be tile 
DQ2 allele. Sequence analysis has revealed that tlus serologic 
marker consists of two different heterod.imers: DQBl *0201/ 
DQAl *0501 or DQBl *0201 / DQAl *0201. The former is very 
strongly associated with DH; one study showed carriage by all but 
three of 27 patients [2] . The coding for the heterodimer may be by 
cis or trails arrangement of the alleles on each chromosome [IS]. In 
celiac disease, analysis of the DQBl sequence has demonstrated 
that Asp57-negative alleles are involved in both DQ2-positive and 
-negative patients [19]. 
Despite this very strong association with tlle DQ locus, there has 
been speculation that other MHC and non-MHC genes may also 
contribute to susceptibility [1]. The centromeric boundary of the 
"DH haplotype" has been shown not to extend to the HLA-DP 
locus [4]. A more recent study has suggested that there may be as 
many as three d.ifferent d.isease susceptibility loci within the MHC, 
with tbe m~or single contribution by a gene lying closer to the 
complement cluster than to tile class II region [2]. 
In view of the potent immwlOmodulating and proinflanunatory 
actions 3l1d the loca.lization of its gene within the MHC, there has 
been speculation that polymorphism within the TNF-a gene may 
underlie the genetic association of tlus region with autoimmune 
diseases [20,21]. The polymorplusm that we have investigated 
involves a G to A transition at position - 30S [14], in a region of the 
gene that controls tr3l1scription [22,23] . FurthemlOre, the polymor-
phic site is also part of the consensus sequence for the transcription 
f..ctor AP-2 [24]. Using reporter gene constructs under the control 
of the two allelic promoters tr3l1sfected into a human B cell line, we 
have evidence that the TNF2 promoter fragment is a much stronger 
transcriptional inducer (A.G. Wilson, ll.I1published observation). 
Because the Al-BS-DR3 haplotype has been shown to be associ-
ated with higher production levels of TNF-a [11,12] , and TNF2 
fonns part of tlus haplotype, it seems reasonable to speculate that 
tlus polymorplusm may directly be responsible for this haplotype/ 
phenotype association. 
Linear IgA disease is also a chronic vesicular skin d.isease 
characterized by linear IgA 3l1d C3 deposits at the basement 
membrane region, as opposed to the granular deposits fOll.l1d in 
DH. Susceptibility to this disease is also associated with the HLA 
AI-BS-DR3-DQ2 haplotype [25]. It is interesting that carriage of 
TNF2 has been reported to be associated with a worse prognosis 
and longer disease duration than when TNFl is present. * Clin.ical-
severity grading ofDH is d.ifficult, but it may be that TNF2 is also 
a severity marker in tlus cond.ition. 
Our results are in keeping with the major susceptibility locus 
lying in the class II region. Whether the association of TNF2 witll 
DH is due to linkage disequilibrium or represents a second minor 
susceptibility locus will need further investigation. Examination of 
TNF-a genotypes in ethnic groups that show d.ifferent MHC 
associations with DH may be the best way to answer trus question. 
' Collier PM, Wojnarowska F, McGuire 13, Welsh K: Polymorph.ism of 
the tumor necrosis factor a promoter region is strongly associated with 
tinear IgA disease and a/fects prognosis (abstr). B,. J Denllalol 131 (suppl 
4):22 , 1994. 
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